Skip to main content

Table 2 Histamine receptor polymorphisms in patients with PD and healthy controls.

From: Genetic variability of histamine receptors in patients with Parkinson's disease

GENOTYPE

PATIENTS WITH PD NO (%)

HEALTHY SUBJECTS NO (%)

INTERGROUP COMPARISON VALUES ODDS RATIO (95% C.I) [CHI-SQUARE; P VALUE]

H1 Leu/Leu

193 (99.0)

231 (100)

0.46a (0.46–1.34) [2.38; 0.123]

H1 Leu/Ser

2 (1.0)

0 ---

2.20 a (0.75–2.20) [2.38; 0.123]

H1 Ser/Ser

0 ---

0 ---

---

H2 -1018 G/G

183 (93.9)

208 (90.0)

1.69 (0.83–3.44) [2.03; 0.154]

H2 -1018 G/A

10 (5.1)

23 (10.0)

0.49 (0.23–1.04) [3.44; 0.063]

H2 -1018 A/A

2 (1.0)

0 ---

2.20 a (0.75–2.20) [2.38; 0.123]

Total

195

231

 

HRH1 Allele frequency

   

H1 Leu

388 (99.5)

462 (100)

0.46 a (0.46–1.34) [2.37; 0.124]

H1 Ser

2 (0.5)

0 (0)

2.19 a (0.74–2.19) [2.37; 0.124]

Total

390

462

 

HRH2 Allele frequency

   

H2 -1018 G

376 (96.4)

439 (95.0)

1.41 (0.72–2.74) [0.98; 0.322]

H2 -1018 A

14 (0.6)

23 (5.0)

0.71 (0.37–1.39) [0.98; 0.322]

Total

390

462

 
  1. Crude Odds ratios are shown. (a) In cases where comparison values included zero the relative risk ratio is shown instead of the Odds Ratio.